PHARMACEUTICAL
PHARMACEUTICAL MICROBIOLOGY
Read articles about pharmaceutical microbiology from Microbiologics’ experts and other field experts.
Antibiotic-Resistant Gonorrhea: A Growing Global Crisis
At any given time, one in five people in the US has a sexually transmitted infection (STI), translating to more than 68 million infections.1 These infections cost billions in healthcare expenses each year. Even more alarming, over 48% of all new STIs in this country...
Growth Promotion Testing (GPT): Practical Guidance for Confident, Consistent Media Qualification
Growth Promotion Testing (GPT) is a routine and essential part of microbiological quality control for sterile and non-sterile pharmaceutical laboratories. When media qualification practices are aligned with day-to-day testing practices, they support consistent...
The Zodiac, Reimagined Through Microbiology
Lab Week is a time to recognize the people who keep science moving forward every day. From routine quality control to complex problem solving, laboratory professionals bring focus, resilience, and a deep sense of purpose to their work. They also bring something less...
Invisible Variability: The Hidden Costs of In-House QC Organisms
The risk isn’t the method. It’s the variability of the in-house QC organisms. Imagine this, you’ve set up your weekly Growth Promotion plates and the recovery is not meeting specification. You initiate an investigation to find the root cause: you review pipette...
Tuberculosis Research: Why M. tuberculosis Remains One of the World’s Most Resilient Pathogens
Despite decades of research and treatment options, tuberculosis (TB) remains one of the world’s most devastating infectious diseases, claiming more than one million lives each year and continuing to challenge global public health efforts.1, 2, 3 Drug resistance,...
Delivering Confidence: How Inactivation, Quality Processes, and Documentation Ensure Reliable Viral Materials
Choosing a virology services provider is often framed around tangible transactional capabilities, virus stock inventory, assay panel availability, or specialized techniques. But experienced service teams know that technical execution is only as strong as the quality...
The Unique Challenges of Quality Control for Live Biotherapeutic Products
Live Biotherapeutic Products (LBPs) are drug products designed to prevent, treat, or cure disease using living microorganisms. These therapeutics present unique challenges for quality control, especially in the development of microbial safety methods. This blog post...
Ensuring Biopharmaceutical Safety: Integrating Viral Safety and Mycoplasma Testing
Adventitious agent testing is critical to ensure patient safety and maintain product integrity. Biopharmaceuticals, often derived from living cells, are susceptible to contamination by viruses and mycoplasmas, which can be introduced during cell culture, raw material...
QC Compliance and Environmental Isolates
Why are many laboratories incorporating Environmental (a.k.a. In-House) Isolates in their Quality Control testing? There has been a shift in the industry regarding the inclusion of environmental isolates as test strains utilized for microbiological assays. Omission of...
A New Multidrug-Resistant Fungus Emerges
We take it for granted that in the age of antibiotics there will always be a drug available to treat an infection. But reports of outbreaks of a pan-resistant fungal disease known as Candida auris– that is resistant to every antifungal medication physicians have to...
